Clinical Trial Update: Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies

View source ↗

Summary

A standardized Italian network is enrolling individuals who have islet autoantibodies to study progression toward Type 1 diabetes, with the study currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Impaired Glucose Tolerance
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Società Italiana di Endocrinologia e Diabetologia Pediatrica | Conditions: Type 1 Diabetes (T1D), Autoantibodies | Status: NOT_YET_RECRUITING